GILEAD SCIENCES, INC.

13D and 13G Filings

Investors who own more than 5% of a class must file a Schedule 13D or 13G. The latest filing for each security since 12/18/2024, newest first.

Issuer % of Class Filed
Arcus Biosciences, Inc. 13D/A
RCUS · 03969F109
 24.7% 8/7/2026
Event 8/5/2026
Assembly Biosciences, Inc. 13D/A
ASMB · 045396108
 25.1% 5/27/2026
Event 5/22/2026
Arcellx, Inc. 13D/A
ACLX · 03940C100
 100.0% 4/28/2026
Event 4/28/2026
Xilio Therapeutics, Inc. 13G/A
XLO · 98422T100
 19.9% 2/12/2026
Event 12/31/2025
Cypherpunk Technologies Inc. 13G/A
CYPH · 52187K200
 0% 2/12/2026
Event 12/31/2025
Kalaris Therapeutics, Inc. 13G/A
KLRS · 482929106
 3.9% 3/20/2025
Event 3/18/2025
Ikena Oncology, Inc. 13G/A
IKNA · 45175G108
 3.6% 2/13/2025
Event 12/31/2024
Galapagos NV 13D/A
LKFT · 36315X101
 29.9% 1/10/2025
Event 1/7/2025